Pancreatic cancer
Results
Phase 3
This trial looked at the chemotherapy drug gemcitabine alongside a drug called ganitumab for pancreatic cancer that has spread to another part of the body.
Recruitment start: 7 April 2011
Recruitment end: 9 August 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor William Steward
Amgen
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 23 Nov 2015
CRUK internal database number: 8360